Sex and Response to Cardioprotective Conditioning Maneuvers by Querio, G. et al.
fphys-12-667961 May 10, 2021 Time: 15:28 # 1
MINI REVIEW







Medical University of Vienna, Austria
Marisol Ruiz-Meana,






This article was submitted to
Clinical and Translational Physiology,
a section of the journal
Frontiers in Physiology
Received: 15 February 2021
Accepted: 30 March 2021
Published: 14 May 2021
Citation:
Querio G, Geddo F, Antoniotti S,
Gallo MP and Penna C (2021) Sex




Sex and Response to
Cardioprotective Conditioning
Maneuvers
Giulia Querio1, Federica Geddo1, Susanna Antoniotti1, Maria Pia Gallo1* and
Claudia Penna2
1 Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy, 2 Department of Clinical and Biological
Sciences, University of Turin, Turin, Italy
Ischemic heart disease (IHD) is a multifactorial pathological condition strictly related to
genetic, dietary, and lifestyle factors. Its morbidity and mortality rate represent one of
the most important pathological issues that today involve younger people in a stronger
way than in the past. IHD clinical outcomes are difficult to treat and have a high
economic impact on health care. So prevention of this pathological condition through
cardioprotective maneuvers represents the first line of intervention, as already underlined
by several animal and human studies. Even if the time of intervention is important to
prevent severe outcomes, many studies highlight that sex-dependent responses are
crucial for the result of cardioprotective procedures. In this scenario sexual hormones
have revealed an important role in cardioprotective approach, as women seem to be
more protected toward cardiac insults when compared to male counterparts. The aim of
this mini review is to show the molecular pathways involved in cardioprotective protocols
and to elucidate how sexual hormones can contribute in ameliorating or worsening the
physiological responses to IHD.
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INTRODUCTION
Ischemic heart disease (IHD) is a pathological condition characterized by reduced or absent blood
flow in coronary arteries due to total or partial occlusion of these vessels by atherosclerotic plaque
or blood clots formation. This condition causes improper supply of oxygen and nutrients to
myocardial tissue, and, depending on ischemia duration, myocardial cell death can occur. Among
all cardiovascular diseases (CVD), IHD is the leading single cause of death in Europe: IHD mortality
represents 19% of deaths among men and 20% of deaths among women (Kuznetsova, 2018).
Emerging evidences support differences in risk factors, symptoms, and outcomes of IHD between
sexes in an age-related trend (Pagliaro et al., 2020). Data from the CVD statistics point out that
IHD is the leading cause of death in men (16%) and women (11%) under 75, while it is the single
cause of premature mortality in men (16%) under 65 and the second in women compared for the
same age ranges (Wilkins et al., 2017). Ischemia can also be induced during cardiac surgery where
controlled periods of cardiac arrest allow and optimize critical interventions.
Important cellular modifications during prolonged ischemia are linked to mitochondrial
dysfunction and reduced ATP availability and are strictly related to intracellular Ca2+ impairment
as already reviewed elsewhere (Garcia-Dorado et al., 2012). Furthermore, it is now well established
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that reperfusion, that is, the restoration of blood flow, causes
further damage of cardiac tissue, maintaining intracellular Ca2+
overload that exacerbates the harmful effects induced by ischemia
and activates calpain-mediated proteolysis, leading to the
condition commonly designated as “reperfusion injury” (Garcia-
Dorado et al., 2012; Inserte et al., 2012; Kalogeris et al., 2012).
According to the phenomena described, it is accepted
nowadays that ischemia reperfusion injury (IRI) is characterized
by detrimental effects of both ischemia and reperfusion. From
a clinical perspective, even if restoration of blood flow could
be dangerous, it represents the only possible intervention to
have better survival chance when coronary occlusion occurs, and
researches are moving toward new insights to reduce IRI and
improve cardiac outcomes after prolonged ischemia.
Experimental and clinical studies have underlined sex
differences in response to IRI, with women showing most
detrimental outcomes, probably due to improper diagnosis
and poorer prevention procedures than male counterparts
(Garcia et al., 2016). IHD shows indeed different onset and
clinical pictures in the two sexes, and the underestimated
risk for female patients could represent the cause of poorer
outcomes (Maas and Appelman, 2010). Moreover, studies
are addressed to the development of therapeutic approaches
in order to reduce or prevent detrimental effects of IRI
in both pathological condition and cardiac surgery (Penna
et al., 2015). So in the following paragraphs, we will discuss
some cardioprotective maneuvers, in particular pre-conditioning
(PreC), post-conditioning (PostC), and remote conditioning,
that will be presented with a focus on sexual differences to
these interventions, emphasizing the need for a sex-dependent
approach in cardioprotection.
SEX DIFFERENCES IN PHYSIOLOGICAL
CARDIOPROTECTION
Nowadays it is largely accepted that there are different IRI
manifestations in male and female subjects, among all ages
and outcome of cardiac injury. Differences studied and results
obtained suggest a possible role of sexual hormones in
several animal models.
Despite the traditional dualism of estrogens and androgens in
conditioning the cardioprotective responses, mainly highlighted
by experiments from animal models, human studies and
clinical data show a more complex scenario. In this section,
cardioprotective pathways activated by both estrogens and
androgens are presented, with the aim to underline the weakness
of sex-adapted cardioprotective strategies only focused on
these mechanisms.
Estrogen binds to different receptors: estrogen receptor-
α (ER-α), estrogen receptor-β (ER-β), or G-protein coupled
estrogen receptor (GPR30 or GPER). Even if ER-β has a
strategical role in cardioprotection, the involvement of ER-α
against IRI effects is still controversial; nevertheless, consistent
data suggest that estrogen-mediated protective response may
rely on both ERs (Murphy and Steenbergen, 2007b; Deschamps
et al., 2010). Several pathways activated by this hormone can
be seen as the opposite to those activated during ischemia
or reperfusion. In fact, estrogen is involved in the regulation
of ions transporters and exchangers: it induces S-nitrosylation
of L-type Ca2+ channels with a reduction of Ca2+ loading,
and it regulates Ca2+ uptake in mitochondria through the
extracellular signal-regulated kinases (ERK1/2) (Iorga et al.,
2017). Despite reactive oxygen species (ROS) increase being
directly related to ischemia duration, it has been demonstrated
that estrogen increases mitochondrial biogenesis and reduces
ROS production in these cellular compartments. The hormone
is also involved in the upregulation of nitric oxide synthases
(NOS), through PI3-K pathway, with the consequent rise in
NO production that has a primary role in activating protein
kinase G (PKG) that enhances KATP channels activity and
inhibits mPTP opening. Evidences show that mitochondrial
preservation induced by estrogen could also be mediated by
STAT3 activation through tumor necrosis factor receptor 2
(TNFR2) (Wang et al., 2008). Furthermore, estradiol decreases
connexin-43 (Cx-43) dephosphorylation, which has been shown
to be cardioprotective toward IRI (Murphy and Steenbergen,
2007a,b; Wang et al., 2020).
Cardioprotection in female hearts involves also endogenous
antioxidant systems: catalase, superoxide dismutase (SOD),
glutathione (GSH), and GSH peroxidase (GPx) are highly
expressed if compared to male counterparts (Casin and Kohr,
2020). Moreover, female cardiomyocytes show high ascorbate
redox homeostasis and enhanced nitrate-to-nitrite conversion
that elevates NO production (Lim et al., 2009).
Other animal studies centered their work in the evaluation
of the effect of testosterone in cardioprotection, and like
estrogen, androgens can activate both genomic and non-
genomic responses by binding to androgen receptors (AR)
(Lucas-Herald et al., 2017).
There are several factors through which androgens may have
a role in cardioprotection (Bell et al., 2011; Pongkan et al., 2015,
2016; Lucas-Herald et al., 2017). In fact, testosterone is involved
in physiological mitochondrial ROS generation (Pagliaro and
Penna, 2015); it is also able to activate the PI3-K pathway
increasing endothelial NOS (eNOS) activity and NO production.
Testosterone is involved in the upregulation of sarcoplasmic
reticulum Ca2+ release channels (SERCA) and activation of
L-type calcium channels, and it has been observed that in severe
ischemic condition it may contribute to Ca2+ overload suggesting
that specific context may modulate the response to this sexual
hormone (Murphy and Steenbergen, 2007a; Wang et al., 2008).
The positive or negative roles of androgens in cardiac tissue are
under investigation, but it is already known that testosterone
can be converted to estrogen by aromatase, and through this
modification it can activate cardioprotective effects induced by
the other sexual hormone.
So reducing the cardioprotective difference between the two
sexes relying only on sexual hormones could be limiting in the
management of IRI, and it is not supported by pharmacological
interventions, with synthetic estrogens that demonstrated
detrimental effects in postmenopausal women after IRI (Hulley
et al., 1998; Anderson et al., 2004; Sivasinprasasn et al., 2016).
Furthermore, new insights underline the involvement of several
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determinants in male and female manifestations of IRI, among
which are anatomical, physiological, and genetic factors (Luczak
and Leinwand, 2009; Regitz-Zagrosek and Kararigas, 2017; Stone
et al., 2019; Litviňuková et al., 2020).
SEX AND CARDIOPROTECTIVE
MANEUVERS
Regarding the deleterious effects induced by IRI, future
challenges for clinical procedures are addressed to the reduction
of reversible or not reversible injury of cardiac tissue and the
enhancement of cardioprotection. Conditioning maneuvers
figure as intriguing protocols that revealed successful results
in animal models of IRI, but their potential application to
humans seems to underline some difficulties. In particular,
PreC is not applicable in pathological settings because of
ischemic unpredictability, and only a few clinical trials develop
this protocol in cardiac surgery, while PostC seems to be
more applicable after ischemic injury even if the window
of protection occurs only a few minutes after reperfusion
(Kloner and Rezkalla, 2006; Vinten-Johansen et al., 2007).
Remote conditioning probably is the most plausible procedure
to induce cardioprotection in clinical settings, and several
clinical trials are developed to study the advantageous use of
this maneuver (Candilio et al., 2011; Pedersen et al., 2018;
England et al., 2019). There are plenty of data focusing on
the cardioprotective effects of conditioning maneuvers on
animal models, and only a few clinical trials developed in
humans show contrasting results underlining the difficult
translatability of these protocols to clinics (Kloner and
Rezkalla, 2006; Peart and Headrick, 2009; Heusch, 2013).
The following paragraphs show different sex responses to
conditioning procedures in animal models, focusing on
possible application to humans. Human studies and most
relevant clinical trials based on the effect of conditioning are
summarized in Table 1.
PreC
Among cardioprotective maneuvers PreC, is a possible
therapeutic approach to limit the damaging effect of IRI.
PreC consists of brief periods of ischemia and reperfusion (I/R)
before the infarcting ischemia; it could be performed through
mechanical or pharmacological stimulation or with exercise
(Penna et al., 2020). According to its temporal application
PreC could be used prior to cardiac surgery interventions,
like coronary artery bypass graft surgery (CABG), but it is still
difficult to perform PreC in the prevention of other unpredictable
cardiac outcomes that involve IRI. Cardioprotection induced
by PreC has been demonstrated to involve different molecular
pathways that contribute to mitochondrial preservation through
the inhibition of mPTP opening; among them are cGMP/PKG
pathway that is involved in the production of NO through
Akt/eNOS activation, the reperfusion injury savage kinase
(RISK) pathway that activates ERK1/2 and GSK3β, and the
survivor activating factor enhancement (SAFE) pathway that
activates STAT3 responses (Heusch, 2013; Penna et al., 2015).
Given the effect of PreC, and the implications of sex hormones
in cardioprotection, it could be interesting to evaluate if there are
different responses to PreC in male and female subjects.
In order to assess any difference between sexes in PreC
followed by ischemia, it has been evidenced in animal models
that not only sex but also age influences the resulting
cardioprotection: in fact, young female animals show no response
to PreC presumably due to incomplete sexual maturation, while
male subjects show cardioprotection after PreC at any age
(Turcato et al., 2006).
Furthermore, several studies underline positive effects of
PreC before IRI in males but no effects or worst injury in
female subjects. Some results suggest that the female heart is
physiologically protected by estrogen, and thus the effect of PreC
can be insufficient to overcome that of the sexual hormone,
while male subjects benefit at all ages from the treatment with
PreC. To support this hypothesis, some groups underline the
role of different cardioprotective mediators in PreC and their
physiological expression in the two sexes: KATP channels and heat
shock proteins (HSP) that are constitutively more activated in
females (Ranki et al., 2002; Deschamps et al., 2010), the enzymatic
or non-enzymatic capability to control increasing ROS that is
more evident in female hearts (Casin and Kohr, 2020), and PI3-
K/NOS pathway activation through Notch1 and GPR30 that is
more expressed in female hearts (Rocca et al., 2018). On the
other hand, a study by Lieder and collaborators underlines no
sex differences after PreC treatment of rat hearts showing no
sex-dependent differences in infarct size; the authors discuss
their results underlining that diverging data in this field could
be caused by animal models or different experimental protocols
(Lieder et al., 2019). In this scenario, it is highly supported that
female cardioprotection induced by PreC can be reached only
if cardiac insults overcome a stress threshold that makes the
existing estrogen protection insufficient (Song et al., 2003; Pitcher
et al., 2005); lack of clinical trials or human studies that show
different responses in the two sexes compels this consideration
only to a theoretical field.
PostC
Another cardioprotective intervention that can be used to reduce
IRI is PostC: brief intermittent cycles of I/R mechanically or
pharmacologically induced in the onset of reperfusion. PostC
activates different intracellular responses; the most studied are
the cGMP/PKG pathway, the RISK pathway, and the SAFE
pathway that all contribute to mitochondrial preservation and
limit cardiac damage (Heusch, 2013). Emerging clinical studies
are addressed to translate animal model results to humans, also
because PostC has a great clinical potential and its application
could be promising in cardioprotective strategies (Vinten-
Johansen et al., 2007). As seen in PreC, it could be reasonable to
think that differences between sexes can also be found in PostC
responses (Skyschally et al., 2009).
It has been observed that after PostC only males show
improved post-ischemic recovery of function, and protective
effects of PostC in male subjects involve different factors,
such as reduced superoxide production, increased MnSOD
expression, reduced Bax/Bcl-2 ratio, and reduced caspase-3
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TABLE 1 | Human studies and most relevant clinical trials based on the effect of conditioning maneuvers and their effect in the two sexes.
Intervention Cardioprotective maneuver Effect of the treatment Sex differences References
Coronary angioplasty for acute
myocardial infarction
PostC Reduction in infarct size and
attenuation of no reflow
No sex differences studied Staat et al., 2005
Primary percutaneous coronary
intervention in STEMI
Combination of RIC and PostC Improvement of myocardial
salvage index. No differences in
infarct size and microvascular
occlusion
No sex differences studied Eitel et al., 2015
Primary percutaneous coronary
intervention in STEMI




Sloth et al., 2015
Elective coronary bypass
grafting




Kleinbongard et al., 2016
Primary percutaneous coronary
intervention in STEMI
RIPC Reduction in enzymatic infarct
size. Improvement of
T2-weighted edema volume.
ST-segment resolution > 50%
No sex differences studied Crimi et al., 2013
STEMI, ST-segment elevation myocardial infarction; PostC, post-conditioning; RIC, remote ischemic conditioning; RIPC, remote ischemic post-conditioning.
FIGURE 1 | Cardioprotective pathways activated by conditioning maneuvers and sex-related response. Animal models suggest that males (M) seem to respond
better to conditioning cardioprotective maneuvers through the activation of cGMP-PKC (1), RISK (2) and SAFE (3) pathways than female (F) that constitutively
express these pathways. Figure created in BioRender.com.
activation (Ciocci Pardo et al., 2018). Furthermore, after PostC
male hearts also show higher expression in p-Akt, p-GSK3β and
p-PKCε, while female expression of these intracellular mediators
has no changes after the treatment (Ciocci Pardo et al., 2018).
Moreover, Inserte and collaborators show that in male Sprague–
Dawley rat hearts, PostC activates the cGMP/PKG pathway that is
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involved in cardioprotection through the delaying normalization
of intracellular pH (Inserte et al., 2011). Studies on animal models
show that PostC maneuvers have effects only in male hearts; lack
of data in female animal models make it difficult to define clear
differences between sexes.
Regarding all the molecular responses to PostC in males
hearts, it could be speculated that PostC response is also strictly
related to sex hormones showing that probably it activates
pathways that are already highly expressed in females due to
estrogen stimulation; so to have PostC cardioprotective effect,
it could be reasonable that female hearts have to be exposed
to higher injury (Crisostomo et al., 2006; Penna et al., 2009).
Some human clinical trials and meta-data analysis underline
no beneficial effect of PostC application, but the different sex
response was not considered by these studies (Eitel et al., 2015;
Xing et al., 2019), while other works show a positive effect
of PostC in reducing infarct size, but no sex differences were
outlined (Staat et al., 2005). Furthermore, some evidences also
underline that the hearts of women treated with PostC showed
worse outcomes compared to untreated women, pointing out
the need for deeper investigations on the possible application of
PostC in female patients (Shin et al., 2019).
Remote Conditioning
Remote ischemic conditioning (RIC) is considered among
cardioprotective maneuvers; it consists of brief cycles of ischemia
and reperfusion in a peripheral organ or tissue (even in arms or
legs), remote from the heart (Przyklenk et al., 1993). It can be
induced before (remote PreC), during (remote per-conditioning),
or after (remote PostC) an index ischemia (Penna et al., 2015). It
is a non-invasive and low-cost procedure that can be performed
through an inflating/deflating pneumatic cuff to induce 5 min
cycles of ischemia/reperfusion favoring the protection induced by
RIC (Hausenloy et al., 2020). Clinical benefits of this procedure
are still debated (Hausenloy et al., 2019, 2020), but recent findings
point out a possible role of humoral factors released after RIC that
have an age- and sex-dependent protective role (Heinen et al.,
2018). In particular, Heinen et al. (2018) point out a significant
protective role of humoral factors derived from young males
exposed to RIC in reducing infarct size, and this is probably due
to the phosphorylation of GSK3β that is involved in the inhibition
of mPTP through the RISK pathway. Furthermore, a recent
work by Lieder et al., reported no differences in cardioprotection
in a specific RIC model (Lieder et al., 2019). Clinical data
suggest controversial results on the efficacy of RIC, some of
them showing no cardioprotection (García Del Blanco et al.,
2021), while others underlining cardioprotective effects of RIC
with no sex differences (Crimi et al., 2013; Eitel et al., 2015;
Sloth et al., 2015; Kleinbongard et al., 2016). Insufficient data in
animal and clinical studies point out differences between sexes
in cardioprotective effects of RIC, and some authors suggest
estrogens as possible confounding factors that make difficult
the interpretation of limited data regarding the role of RIC
in female subjects (Brevoord et al., 2012; Lieder et al., 2019;
Shaban and Leira, 2019).
CONCLUSION
In this brief report, we have outlined different responses in female
and male hearts to IRI, and in particular we focused on a primary
role of estrogens in cardioprotection. Some of the most studied
cardioprotective maneuvers, in order to reduce IRI, have been
described with a particular focus on females and males’ different
responses. The overview outlined here shows that differences
between sexes in cardioprotective interventions could be linked,
but not exclusively, to the physiological role of sexual hormones
that change throughout the lifespan highlighting a complex
relationship toward age and sex in response to cardioprotective
maneuvers. In conclusion, sex and age differences have to
be considered in cardioprotection in order to optimize the
clinical application of these procedures. As Figure 1 shows,
we have focused on intrinsic cardioprotective mechanisms that
can be elicited by conditioning maneuvers as in our opinion
it is important to understand the sex-related differences in
these mechanisms before moving on to testing pharmaceutical
approaches. Furthermore, a deeper knowledge of the protective
pathways activated by the different conditioning maneuvers in
the two sexes represents a crucial point for clinical interventions.
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Litviňuková, M., Talavera-López, C., Maatz, H., Reichart, D., Worth, C. L., and
Lindberg, E. L. (2020). Cells of the adult human heart. Nature 24, 1–7. doi:
10.1038/s41586-020-2797-4
Lucas-Herald, A. K., Alves-Lopes, R., Montezano, A. C., Ahmed, S. F., and
Touyz, R. M. (2017). Genomic and non-genomic effects of androgens in the
cardiovascular system: clinical implications. Clin. Sci. 131, 1405–1418. doi:
10.1042/CS20170090
Luczak, E. D., and Leinwand, L. A. (2009). Sex-Based Cardiac Physiology. Annu.
Rev. Physiol. 71, 1–18. doi: 10.1146/annurev.physiol.010908.163156
Maas, A. H. E. M., and Appelman, Y. E. A. (2010). Gender differences in coronary
heart disease. Neth. Heart J. 18, 598–602. doi: 10.1007/s12471-010-0841-y
Murphy, E., and Steenbergen, C. (2007a). Cardioprotection in females: a role for
nitric oxide and altered gene expression. Heart Fail. Rev. 12, 293–300. doi:
10.1007/s10741-007-9035-0
Murphy, E., and Steenbergen, C. (2007b). Gender-based differences in mechanisms
of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 75,
478–486. doi: 10.1016/j.cardiores.2007.03.025
Pagliaro, P., and Penna, C. (2015). Redox signalling and cardioprotection:
translatability and mechanism. Br. J. Pharmacol. 172, 1974–1995. doi: 10.1111/
bph.12975
Pagliaro, P., Femminò, S., Thairi, C., Comità, S., Alloatti, G., and Penna, C.
(2020). Sex and Gender Differences in Cardiovascular Diseases. Cond. Med. 3,
274–284.
Peart, J. N., and Headrick, J. P. (2009). Clinical cardioprotection and the value of
conditioning responses. Am. J. Physiol. Heart Circ. Physiol. 296, H1705–H1720.
doi: 10.1152/ajpheart.00162.2009
Pedersen, T. F., Budtz-Lilly, J., Petersen, C. N., Hyldgaard, J., Schmidt, J. O., Kroijer,
R., et al. (2018). Randomized clinical trial of remote ischaemic preconditioning
versus no preconditioning in the prevention of perioperative myocardial
infarction during open surgery for ruptured abdominal aortic aneurysm. BJS
Open 2, 112–118. doi: 10.1002/bjs5.55
Penna, C., Alloatti, G., and Crisafulli, A. (2020). Mechanisms Involved in
Cardioprotection Induced by Physical Exercise. Antioxid. Redox Signal. 32,
1115–1134. doi: 10.1089/ars.2019.8009
Penna, C., Granata, R., Tocchetti, C. G., Gallo, M. P., Alloatti, G., and Pagliaro, P.
(2015). Endogenous Cardioprotective Agents: role in Pre and Postconditioning.
Curr. Drug Targets 16, 843–867. doi: 10.2174/1389450116666150309115536
Penna, C., Tullio, F., Merlino, A., Moro, F., Raimondo, S., Rastaldo, R.,
et al. (2009). Postconditioning cardioprotection against infarct size and post-
ischemic systolic dysfunction is influenced by gender. Basic Res. Cardiol. 104,
390–402. doi: 10.1007/s00395-008-0762-8
Frontiers in Physiology | www.frontiersin.org 6 May 2021 | Volume 12 | Article 667961
fphys-12-667961 May 10, 2021 Time: 15:28 # 7
Querio et al. Sex and Cardioprotective Maneuvers
Pitcher, J. M., Wang, M., Tsai, B. M., Kher, A., Turrentine, M. W., Brown, J. W.,
et al. (2005). Preconditioning: gender effects. J. Surg. Res. 129, 202–220. doi:
10.1016/j.jss.2005.04.015
Pongkan, W., Chattipakorn, S. C., and Chattipakorn, N. (2015). Chronic
testosterone replacement exerts cardioprotection against cardiac ischemia-
reperfusion injury by attenuating mitochondrial dysfunction in testosterone-
deprived rats. PLoS ONE 10:e0122503. doi: 10.1371/journal.pone.0122503
Pongkan, W., Chattipakorn, S. C., and Chattipakorn, N. (2016). Roles
of Testosterone Replacement in Cardiac Ischemia-Reperfusion Injury.
J. Cardiovasc. Pharmacol. Ther. 21, 27–43. doi: 10.1177/1074248415587977
Przyklenk, K., Bauer, B., Ovize, M., Kloner, R. A., and Whittaker, P. (1993).
Regional ischemic ‘preconditioning’ protects remote virgin myocardium from
subsequent sustained coronary occlusion. Circulation 87, 893–899. doi: 10.
1161/01.cir.87.3.893
Ranki, H. J., Budas, G. R., Crawford, R. M., Davies, A. M., and Jovanović, A. (2002).
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